A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Hand, Foot and Mouth Disease on the Rise
Preparing for the Hazards of Winter Weather
BayCare Reveals Pagidipati Children's Hospital at St. Joseph's
Why Identity Governance Is Becoming a Facilities Management Issue
Habitat Health Opens South Los Angeles PACE Center